- FROM THE ANALYST'S COUCH
Mitigating bias in pharmaceutical R&D decision-making
Access options
Access Nature and 54 other Nature Portfolio journals
Get Nature+, our best-value online-access subscription
$29.99 / 30 days
cancel any time
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Rent or buy this article
Prices vary by article type
from$1.95
to$39.95
Prices may be subject to local taxes which are calculated during checkout
Nature Reviews Drug Discovery 21, 874-875 (2022)
doi: https://doi.org/10.1038/d41573-022-00157-4
Acknowledgements
The authors would like to thank K. Smietana, S. Visser, R. Lalonde and B. Weber for their inputs while participating in the earlier stages of this project, as well as B. Metzler with her diligent input on the manuscript writing. Special thanks go to the anonymous survey participants who gave their input and often provided insights via their additional comments.
Supplementary Information
Competing Interests
The authors declare no competing interests.